Episurf Medical AB (publ)
SSE:EPIS-B.ST
0.98 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10.3 | 6.6 | 6.5 | 5 | 4.9 | 4 | 2.49 | 2.406 | 1.016 | 0.173 | 0.038 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 104.7 | 4.2 | 4.8 | 5.1 | 4.5 | 3.3 | 60.536 | -1.605 | 46.01 | 21.303 | 16.983 | 11.567 | 0 | 0 | 0 |
| Gross Profit
| -94.4 | 2.4 | 1.7 | -0.1 | 0.4 | 0.7 | -58.046 | 4.011 | -44.994 | -21.13 | -16.945 | -11.567 | 0 | 0 | 0 |
| Gross Profit Ratio
| -9.165 | 0.364 | 0.262 | -0.02 | 0.082 | 0.175 | -23.309 | 1.667 | -44.265 | -122.119 | -446.907 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 8.3 | 11.6 | -6.9 | -4.1 | -5.5 | -9.7 | 3.709 | -1.605 | 0.466 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 1.2 | 1.1 | 0 | 0 | 0.485 | 0.325 | 0.456 | 0.222 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.567 | 7.569 | 3.793 | 0 |
| SG&A
| -5.6 | -9.3 | -4.4 | 1.2 | 1.1 | -4.3 | 33.3 | 0.485 | 0.325 | 0.456 | 0.222 | 11.567 | 7.569 | 3.793 | 0 |
| Other Expenses
| 0 | 79.4 | 78 | 66.2 | 73.6 | 67.9 | 63.642 | 32.959 | 23.441 | 12.131 | 5.259 | 4.736 | -2.587 | -1.015 | 0.541 |
| Operating Expenses
| 2.7 | 79.4 | 71.1 | 63.3 | 69.2 | 58.2 | 63.642 | 64.114 | 45.025 | 33.434 | 23.318 | 16.303 | 4.982 | 2.778 | 0.541 |
| Operating Income
| -97.1 | -77 | -69.4 | -63.9 | -68.8 | -57.5 | -61.152 | -61.709 | -43.975 | -33.261 | -23.28 | -16.303 | -4.982 | -2.778 | -0.541 |
| Operating Income Ratio
| -9.427 | -11.667 | -10.677 | -12.78 | -14.041 | -14.375 | -24.557 | -25.652 | -43.262 | -192.233 | -613.98 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.5 | -0.2 | 0.2 | 2 | -1 | -0.3 | 0.058 | 0.041 | 0.034 | 0.347 | -0.653 | 0.533 | 0.523 | -0.008 | 0 |
| Income Before Tax
| -94.6 | -77.2 | -69.2 | -63.9 | -69.8 | -57.8 | -61.094 | -61.667 | -43.975 | -32.914 | -22.857 | -15.77 | -4.459 | -2.786 | -0.54 |
| Income Before Tax Ratio
| -9.184 | -11.697 | -10.646 | -12.78 | -14.245 | -14.45 | -24.533 | -25.635 | -43.262 | -190.228 | -602.825 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.2 | 0.1 | 0.3 | 0.7 | 0.8 | 0.4 | -0 | 0.044 | 0.035 | 0.353 | -0.65 | 0.533 | 0.527 | 0 | 0 |
| Net Income
| -94.8 | -77.3 | -69.5 | -64.6 | -70.6 | -57.8 | -61.093 | -61.667 | -43.975 | -32.914 | -22.857 | -15.77 | -4.459 | -2.786 | -0.54 |
| Net Income Ratio
| -9.204 | -11.712 | -10.692 | -12.92 | -14.408 | -14.45 | -24.533 | -25.635 | -43.262 | -190.228 | -602.825 | 0 | 0 | 0 | 0 |
| EPS
| -0.36 | -0.29 | -0.31 | -0.4 | -1.05 | -1.71 | -1.69 | -2.52 | -2.08 | -1.76 | -1.24 | -1.04 | -0.29 | -0.51 | -0.08 |
| EPS Diluted
| -0.36 | -0.29 | -0.31 | -0.4 | -1.05 | -1.71 | -1.69 | -2.52 | -2.08 | -1.76 | -1.24 | -1.04 | -0.29 | -0.51 | -0.08 |
| EBITDA
| -91.1 | -69.1 | -61.6 | -55.6 | -61.6 | -52.3 | -56.905 | -57.608 | -41.739 | -31.147 | -21.778 | -15.196 | -4.168 | -2.657 | -0.537 |
| EBITDA Ratio
| -8.845 | -10.47 | -9.477 | -11.12 | -12.571 | -13.075 | -22.851 | -23.947 | -41.063 | -180.013 | -574.38 | 0 | 0 | 0 | 0 |